UF and UF Health faculty, postdoctoral fellows, and graduate students submitted a record number of original research presentations for the American Diabetes Association’s 74th Scientific Sessions held June 13-17, 2014 at the Moscone Center in San Francisco, California. This year's submissions represent one of the largest showcases of research emanating from UF.
A new University of Florida pilot study is helping researchers better understand the trajectory of Type 1 diabetes and may one day help lead to interventions to prevent the disease.
Four distinguished UF Health diabetes experts will be heading 'Down Under' to Australia during the first week of December to highlight Type 1 diabetes (T1D) research work at the 13th International Congress of the Immunology Diabetes Society (IDS) in Lorne, Australia.
Although it has been over 90 years since insulin was discovered, many people around the globe with T1D still lack access. Dr. Mark Atkinson, and his colleagues recently published an article in the journal Diabetes Care, to illustrate the need for global insulin. "We can change the current realities that exist so that all can benefit from advances in diabetes management & care."
In an interview with International Innovation, Todd Brusko, PhD, explains how changes in the field of diabetes research are giving his team of scientists at the UF Diabetes Center of Excellence new opportunities and hope to be able to translate their laboratory findings into clinical treatments. Currently, his team is investigating treatments for type 1 diabetes based on their experiments with regulatory T cells, known as “Tregs.” Learn more.
The NATCO Annual Meeting is the premier meeting where transplant and procurement practitioners join together to learn cutting-edge skills and collaborate with colleagues from all areas of their profession.
University of Florida investigators Brian S. Wilson, MD, PhD, and Mark Atkinson, PhD, have teamed up with colleagues at the City of Hope National Medical Center in Duarte, Calif., to devise a new combination therapy that reverses established type 1 diabetes in mice.
You can listen to an interview on Diabetes Radio with Mark Atkinson, PhD, Desmond Schatz, MD, and Robert Levine, MD, or read about GRAS in the American Diabetes Association publication, Diabetes.
"UF works to unlock causes and cures so kids like Matt Danner won’t be sidelined by their disease." Florida Magazine recently featured an article highlighting the UF Diabetes Center researchers, physicians, and a special patient, Matt Danner.
A cure for Type 1 diabetes has been the holy grail for researchers worldwide since the first clinical trials seeking to cure the disease began some three decades ago. But despite many advances, the target still seems just out of reach.